Penn Medicine Provider
Dermatology
Robert G. Micheletti, MD
4.9
(366)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
View 1 additional location

About me

  • Chief of Hospital Dermatology
  • Chief of Dermatology, Pennsylvania Hospital
  • Director, Cutaneous Vasculitis Clinic, Penn Vasculitis Center
  • Director, Dermatology Medical Student Elective
  • Associate Professor of Dermatology at the Hospital of the University of Pennsylvania
  • Associate Professor of Dermatology in Medicine (General Internal Medicine)

Education and training

  • Medical School: Duke University School of Medicine
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

366 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
expert care
May 2025
5.0
5.0
professional
April 2025
5.0
5.0
the doctor was awesome
April 2025
5.0
5.0
competent

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital
Dr. Micheletti is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Valdemar Wendelboe Nielsen BSc, Michelle A. Lowes MBBS PhD, Ashley Yates PA, Afsaneh Alavi MD, Richard Flowers MD, Iltefat Hamzavi MD, Joslyn Kirby MD MS Med, Robert Micheletti MD, Christopher Sayed MD, Haley B. Naik MD MHSc A Multi-Site Registry of Patients with Hidradenitis Suppurativa – Insights from HS PROGRESS , Society of Investigative Dermatology: 2025


Radhika Gupta BA, Robert Micheletti MD, Victoria Fang PhD, MD Patient-reported outcomes of glucagon-like peptide-1 agonists on hidradenitis suppurativa severity , Society of Investigative Dermatology: 2025


Alhusayen R, Dienes S, Lam M, Alavi A, Alikhan A, Aleshin M, Bahashwan E, Daveluy S, Goldfarb N, Garg A, Gulliver W, Jaleel T, Kimball AB, Kirchhof MG, Kirby J, Lenczowski J, Lev-Tov H, Lowes MA, Lara-Corrales I, Micheletti R, Okun M, Orenstein L, Poelman S, Piguet V, Porter M, Resnik B, Sibbald C, Shi V, Sayed C, Wong SM, Zaenglein A, Veillette H, Hsiao JL, Naik HB. North American Clinical Practice Guidelines for the Medical Management of Hidradenitis Suppurativa in Special Patient Populations , J Am Acad Dermatol, 92((4)): 2025,825-852


Fang V, Gupta R, Micheletti RG Managing Hidradenitis Suppurativa with Biologics and Small Molecule Inhibitors , Dermatol Clin, 43((2)): 2025,231-245


William Lewis and Robert G Micheletti Dermal Atrophy and Lipoatrophy , Decision-Making in Dermatology: 2025


Robert G Micheletti Cutaneous Vasculitis , Dermatology, 5th Edition: 2025


William Lewis and Robert G Micheletti Epidermal Atrophy , Decision-Making in Dermatology: 2025


Micheletti RG, Rosenbach M, Phillips E, Wintroub B, Shinkai K Cutaneous Drug Reactions , Harrison's Principles of Internal Medicine, 22nd Edition: 2025


Robert G. Micheletti, Luis Requena, and Jeffrey P. Callen Cutaneous Vasculitis and Panniculitis , Rheumatology, 9th Edition: 2025


Wei J, Micheletti RG Hospital Dermatology: Review of Research in 2023-2024 , Cutis, 114((5)): 2024,156-168